- decreased prepulse inhibition / IMPC
STOCK Mgmttm1Iz Tg(CRP-cre)1Iz/Cnrm
Status | Available to order |
EMMA ID | EM:00262 |
International strain name | STOCK Mgmttm1Iz Tg(CRP-cre)1Iz/Cnrm |
Alternative name | floxed(mgmt)-Tg/hCRP-Cre |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(CRP-cre)1Iz, Mgmttm1Iz |
Gene/Transgene symbol | Tg(CRP-cre)1Iz, Mgmt |
Information from provider
Provider | Manfred Rajewsky |
Provider affiliation | Institut fuer Zellbiologie (Tumorforschung), Universitaetsklinikum Essen |
Genetic information | The cre recombinase gene was cloned under control of the human C-reactive protein (hCRP) promoter. The hCRP-promoter is inducible by lipopolysaccharide (LPS) or interleukin 6. Upon induction the cre gene is strongly expressed in hepatocytes, exclusively. The amount of cre-mediated deletion can be controlled by the amount of LPS injected. The percentage of deletion is in the range of 13 to 45%. Exon V of Mgmt was flanked by two loxP-sites. This exon can be spliced out by cre recombinase thereby inactivating the DNA repair activity of the MGMT protein. |
Phenotypic information | No major defects observed. The Tg(CRP-cre) transgene allows the liver-specific, inducible expression of cre recombinase. |
References |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
Literature references
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).